Photo of Kevin Cramer
R United States Senate · North Dakota

Sen. Kevin Cramer

Compare
Total votes
1,044
all sessions
Attendance
96%
45 missed
Near the chamber average
With party
96%
of cast votes
Higher than 81% of chamber peers
Bipartisan score
3%
crosses aisle rarely
Lower than 83% of chamber peers
Sponsored
1,469
bills & resolutions
Near the chamber average
Committees
14
assignments
1,469 bills and resolutions

Sponsored bills

Total
1,469
Primary
67
Co-sponsor
1,402
This page
1,469
matching current filters
Co-sponsor S 1720
In committee · Washington Senate · Co-sponsor
Postal Service Reform Act of 2021

Postal Service Reform Act of 2021 This bill addresses the finances and operations of the U.S. Postal Service (USPS). The bill requires the Office of Personnel Management to establish, within the Federal Employees Health Benefits Program, the Postal Service Health Benefits Program for USPS employees and retirees and provides for coordinated enrollment of retirees under this program and Medicare. The bill repeals the requirement that the USPS annually prepay future retirement health benefits. Additionally, the USPS may establish a program to enter into agreements with an agency of any state government, local government, or tribal government, and with other government agencies, to provide certain nonpostal products and services that reasonably contribute to the costs of the USPS and meet other specified criteria. The USPS must develop and maintain a publicly available dashboard to track service performance and must report regularly on its operations and financial condition. The bill requires mail delivery to occur at least six days a week. The Postal Regulatory Commission must annually submit to the USPS a budget of its expenses. It must also conduct a study to identify the causes and effects of postal inefficiencies relating to flats (e.g., large envelopes). The USPS Office of Inspector General shall perform oversight of the Postal Regulatory Commission.

In committee May 19, 2021 1 co-sponsor
Co-sponsor S 1673
In committee · Washington Senate · Co-sponsor
30 × 30 Termination Act

30 x 30 Termination Act This bill prohibits federal acquisition of land or declaration of a national monument in certain areas and nullifies a provision of an executive order related to conservation. In a state or county where 15% or more of the land is managed by a federal agency (1) federal funds may not be used to acquire nonfederal land unless the agency proposing the acquisition disposes of an equal amount of federal land within the state or county, and (2) a declaration of a national monument shall not apply. The bill prohibits from having the force and effect of law a provision of Executive Order 14008 (86 Fed. Reg. 7619), titled Tackling the Climate Crisis at Home and Abroad , that requires the Department of the Interior to recommend steps to achieve the goal of conserving at least 30% of U.S. lands and waters by 2030. No federal funds may be used to implement, administer, enforce, or carry out any report or program substantially similar to the report or program of such provision. No federal funds may be used to implement, administer, enforce, or carry out any action on federal land that results in a net-loss of multiple use or any principal or major use, unless such action has been authorized by an act of Congress. No federal funds may be used by a federal agency to acquire more than 160 acres of nonfederal land unless the federal agency has received written notice from the state in which the nonfederal land is located that the state has enacted legislation approving the proposed acquisition, and the proposed acquisition has been authorized by an act of Congress.

In committee May 18, 2021 1 co-sponsor
Co-sponsor S 1669
In committee · Washington Senate · Co-sponsor
Military Retiree Survivor Comfort Act

Military Retiree Survivor Comfort Act This bill addresses the overpayment of retired or retainer pay to a joint account (bearing the name of the decedent and the decedent's designated beneficiary) during the month of the death of a retired member of the armed forces. Specifically, the bill authorizes the Department of Defense (DOD) to forgive or offset the overpayment if the decedent was enrolled in the Survivor Benefit Plan (SBP). In the case of an offset, each of the first 12 SBP annuity payments after the death of the retired service member must be reduced by one-twelfth of the overpayment. If the decedent was not enrolled in the SBP, DOD is authorized to forgive the overpayment.

In committee May 18, 2021 1 co-sponsor
Primary S 1654
In committee · Washington Senate · Lead sponsor
A bill to amend the Internal Revenue Code of 1986 to include certain over-the-counter dietary supplement products as qualified medical expenses.

This bill expands the tax deduction for qualified medical expenses to include dietary supplement products. The bill defines dietary supplement products as nutritional products with labelling relating to their effects on bodily functions. The bill also allows payments from certain tax-preferred spending and reimbursement accounts for dietary supplement products.

In committee May 17, 2021 0 co-sponsors
Co-sponsor SRES 212
In committee · Washington Senate · Co-sponsor
A resolution establishing a McCain-Mansfield Fellowship Program in the Senate.

This resolution requires the Office of the Sergeant at Arms and Doorkeeper of the Senate to establish a McCain-Mansfield Fellowship Program through which certain veterans may participate in a two-year fellowship in the personal office of a Senator.

In committee May 13, 2021 1 co-sponsor
Co-sponsor S 1644
In committee · Washington Senate · Co-sponsor
Promising Pathway Act

Promising Pathway Act This bill establishes a provisional approval pathway for medicines intended for serious or life-threatening diseases, including illnesses posing a threat of epidemic or pandemic. The period of the provisional approval is for two years and is potentially renewable. The Food and Drug Administration (FDA) must establish a priority review system to evaluate completed provisional approval applications within 90 days of receipt. A provisional approval application may be approved if the FDA determines that (1) there is substantial evidence of safety for the drug; and (2) there is relevant early evidence of efficacy, based on adequate and well-controlled investigations. During the COVID-19 (i.e., coronavirus disease 2019) pandemic, or another epidemic or pandemic, the FDA must accept and review various portions of a provisional approval application on a rolling basis. The manufacturer of a provisionally approved drug must require patients to participate in an observational registry. A manufacturer that fails to comply with registry requirements is subject to civil penalties. A provisionally approved drug must be labeled as such. If a drug that receives provisional approval status is not brought to market within 180 days of the approval, the approval must be rescinded. The bill also limits the liability of a manufacturer of a provisionally approved drug with respect to any claim under state law alleging that the drug is unsafe or ineffective. Private health insurers and federal health care programs shall not deny coverage of a provisionally approved drug on the basis of it being experimental.

In committee May 13, 2021 1 co-sponsor
Co-sponsor S 1641
In committee · Washington Senate · Co-sponsor
ISRA

Israel Sovereignty Reassurance Act of 2021 or ISRA This bill prohibits using funds made available to the Department of State for FY2022 to implement, administer, or enforce any policy that rescinds the U.S. recognition of the Golan Heights as part of Israel.

In committee May 13, 2021 1 co-sponsor
Showing 1,291 to 1,300 of 1,469 bills